A Study Providing Treatment Access in Participants With Pulmonary Hypertension Completing a Parent Study and Having no Other Option

NCT05179876 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

280

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension, Pulmonary

Interventions

DRUG: Macitentan
DRUG: Selexipag
DRUG: Macitentan/Tadalafil FDC

Sponsor

Actelion